Related Experiment Video
Updated: Mar 26, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.4K
[Pregnancy in patients with cardiomyopathy--cases presentation].
Przeglad Lekarski
|January 29, 2016
Summary
Cardiomyopathy in pregnancy, though rare, poses severe risks and is a growing concern. Successful management requires precise risk assessment and multidisciplinary specialist collaboration for optimal maternal and fetal outcomes.
Area of Science:
- Cardiology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Cardiovascular diseases complicate 0.2-4% of pregnancies in industrialized nations, with increasing prevalence.
- Cardiomyopathy, a heart muscle disease, can impair cardiac function, especially under the increased demands of gestation.
- Cardiomyopathy during pregnancy is infrequent but carries significant risks, contributing to up to 11% of maternal deaths.
Observation:
- This report details clinical cases of cardiomyopathy diagnosed prior to pregnancy.
- Two pregnant patients presented with hypertrophic cardiomyopathy, and one with dilated cardiomyopathy.
- These observations align with existing literature on pregnancy outcomes in women with pre-existing cardiomyopathy.
Findings:
- Pregnancy significantly alters hemodynamic parameters, including blood volume, cardiac output, and vascular resistance.
- Women with pre-existing cardiomyopathy have a limited capacity to adapt to these pregnancy-induced cardiovascular demands.
- Managing cardiomyopathy during pregnancy presents a substantial therapeutic challenge due to these physiological changes.
Implications:
- Accurate risk stratification for both maternal and fetal well-being is paramount for successful management.
- Specialized, experienced counseling is essential, involving a collaborative approach among obstetricians, cardiologists, and anesthesiologists.
- Optimal patient outcomes depend on integrated, multidisciplinary care planning for pregnant individuals with cardiomyopathy.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
687
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
687
01:25Cardiomyopathy I: Introduction and Classification
796
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
796
01:29Cardiomyopathy V: Interprofessional Care
621
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
621
01:29Cardiomyopathy VI: Nursing Management
451
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
451
01:19Mitral Valve Prolapse III: Nursing Management
526
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
526
01:30Cardiomyopathy II: Dilated Cardiomyopathy
744
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
744